Related Experiment Video
Updated: Jan 13, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Clinical Trial Patient Matching: A Real-Time, Common Data Model and Artificial Intelligence-Driven System for
Guannan Gong1,2, Jessica Liu1, Sameer Pandya3
1Yale Cancer Center, Yale School of Medicine, New Haven, CT.
A new AI and NLP tool streamlines cancer clinical trial matching, significantly reducing workload and screening time. This improves patient access to trials by efficiently identifying eligible candidates.
Area of Science:
- Oncology
- Medical Informatics
- Clinical Trial Management
Background:
- Cancer clinical trial enrollment is critically low (5%-7%) due to manual patient-trial matching bottlenecks.
- Existing AI/ML systems lack data standardization and cross-health system compatibility.
Purpose of the Study:
- Develop and validate a semiautomated Clinical Trial Patient Matching (CTPM) tool.
- Enhance the efficiency and scalability of clinical trial recruitment.
Main Methods:
- Created a hybrid rules-based and natural language processing (NLP) pipeline.
- Standardized electronic health record (EHR) data to the Observational Medical Outcomes Partnership (OMOP) common data model.
- Validated CTPM against manual chart review for a colorectal cancer trial, then implemented across 29 trials.
Main Results:
- CTPM achieved 94% retrospective and 88% prospective accuracy for a CRC trial, with 100% sensitivity.
- Reduced chart review workload 10-fold and screening time by 41%.
- Screened 98,348 patients across 29 trials, identifying 825 eligible candidates and facilitating 117 enrollments.
Conclusions:
- AI/NLP tool improves clinical trial recruitment efficiency by focusing research teams on qualified candidates.
- OMOP-based framework enables scalability across health systems.
- Addresses enrollment challenges, potentially increasing patient access to novel cancer therapies.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018